Doses - CITRATE SALTS, POTASSIUM CITRATE, SODIUM CITRATE & CITRIC ACID

Dogs:

For adjunctive therapy to inhibit calcium oxalate crystal formation in dogs with hypocitraturia: Using potassium citrate wax-matrix tablets (Uracit-K®): 150 mg/kg per daydivided into two doses. Crush tablets and mix with food. (Lulich, Osborne et al. 1992)
Monitoring Parameters - Depending on patient's condition, product chosen and reason for use:
1) Serum potassium, sodium, bicarbonate, chloride; 2) Acid/base status; 3) Urine pH, Urinalysis; 4)
Serum creatinine, CBC, particularly in chronic renal failure
Dosage Forms/Preparations/FDA Approval Status/Withholding Times - Veterinary-Approved Products: None

Human-Approved Products:

Potassium Citrate Tablets 5 mEq, 10 mEq; Uracit-K® (Mission); (Rx)
Potassium Citrate Monohydrate 1110 mg/5 ml & Citric Acid Monohydrate 334 mg/5 ml;
Polycitra®-K Syrup (Baker Norton); (Rx)
Sodium Citrate Dihydrate 490 mg/5 ml and Citric Acid Monohydrate 640 mg/5 ml; Oracit®(Carolina Medical); (Rx)
Sodium Citrate Dihydrate 500 mg/5 ml and Citric Acid Monohydrate 334 mg/5 ml; Bicitra®(sugar free) (Baker Norton); (Rx)
Citric Acid monohydrate 334 mg/5 ml, Potassium Citrate monohydrate 550 mg/5 ml and sodiumcitrate dihydrate 500 mg/5 ml; Polycitra® Syrup, Polycitra®-LC Syrup (sugar free) (Baker
Norton); (Rx)
Clavulanate/Amoxicillin ¯ See Amoxicillin/ClavulanateClavulanate/Ticarcillin ¯ See Ticarcillin /Clavulanate